All who are involved in research, counseling, screening, diagnosis, treatment or prevention of hereditairy breast and ovarium cancer are welcome.
This year’s program will feature some extras: many years of collaboration of Hebon in IBCCS has resulted in some exciting findings on the impact of lifestyle and risk factors on risk assessment that will be presented by invited speakers from Great Britain , France and the USA. Two new related studies from Canada and the USA will also be presented.
Location:
Beatrixgebouw Jaarbeurs
Jaarbeursplein
3521 AL Utrecht
Contact:
Do you have questions or comments, please contact:
Denise Jenner: hebon@nki.nl
Phone: 020 512 2484
Colloquium 27 sept 14:00 uur: Optimizing the academic route to patient access of advanced therapies - Eduard Siemerink. Alle info over deze Teams-meeting op https://t.co/YP3WBEucz2 https://t.co/ot9i3kS0Sx
6 oktober: jaarlijkse online nascholing Nierziekten, Kinderwens en Genetica door @UMCUgenetica 👇 aanmelden kan via: https://t.co/1wvwzdTWA7 https://t.co/fMr6hEIR3w
RT @GeneticAMS: Dr. Erik Sistermans, head of AGDx Genome Diagnostics, has been appointed as professor in Human Genetics, in particular pren…